- Home
- BTX vs ATRC Comparison
BTX vs ATRC Comparison
Compare BTX & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTX
- ATRC
- Stock Information
- Founded
- BTX N/A
- ATRC 2000
- Country
- BTX United States
- ATRC United States
- Employees
- BTX N/A
- ATRC N/A
- Industry
- BTX
- ATRC Medical/Dental Instruments
- Sector
- BTX
- ATRC Health Care
- Exchange
- BTX Nasdaq
- ATRC Nasdaq
- Market Cap
- BTX 1.3B
- ATRC 1.5B
- IPO Year
- BTX N/A
- ATRC 2005
- Fundamental
- Price
- BTX $6.97
- ATRC $34.57
- Analyst Decision
- BTX
- ATRC Strong Buy
- Analyst Count
- BTX 0
- ATRC 10
- Target Price
- BTX N/A
- ATRC $49.60
- AVG Volume (30 Days)
- BTX 554.9K
- ATRC 581.4K
- Earning Date
- BTX 01-01-0001
- ATRC 04-29-2025
- Dividend Yield
- BTX 6.11%
- ATRC N/A
- EPS Growth
- BTX N/A
- ATRC N/A
- EPS
- BTX N/A
- ATRC N/A
- Revenue
- BTX N/A
- ATRC $480,076,000.00
- Revenue This Year
- BTX N/A
- ATRC $14.63
- Revenue Next Year
- BTX N/A
- ATRC $12.62
- P/E Ratio
- BTX N/A
- ATRC N/A
- Revenue Growth
- BTX N/A
- ATRC 15.79
- 52 Week Low
- BTX $5.10
- ATRC $18.94
- 52 Week High
- BTX $8.31
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- BTX N/A
- ATRC 60.03
- Support Level
- BTX N/A
- ATRC $31.95
- Resistance Level
- BTX N/A
- ATRC $34.08
- Average True Range (ATR)
- BTX 0.00
- ATRC 1.14
- MACD
- BTX 0.00
- ATRC 0.31
- Stochastic Oscillator
- BTX 0.00
- ATRC 94.66
About BTX BlackRock Technology and Private Equity Term Trust Common Shares of Beneficial Interest
BlackRock Technology and Private Equity Term Trust objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust will invest in equity securities issued by mid - and small capitalization companies that the Trust's adviser believes have above-average earnings growth potential.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.